SI0988302T1 - Benzonaphthyridines - Google Patents
BenzonaphthyridinesInfo
- Publication number
- SI0988302T1 SI0988302T1 SI9830406T SI9830406T SI0988302T1 SI 0988302 T1 SI0988302 T1 SI 0988302T1 SI 9830406 T SI9830406 T SI 9830406T SI 9830406 T SI9830406 T SI 9830406T SI 0988302 T1 SI0988302 T1 SI 0988302T1
- Authority
- SI
- Slovenia
- Prior art keywords
- disorders
- hexahydrobenzo
- naphthyridine
- phenyl
- methyl
- Prior art date
Links
- BJVCSICIEDHBNI-UHFFFAOYSA-N benzo[b][1,8]naphthyridine Chemical class N1=CC=CC2=CC3=CC=CC=C3N=C21 BJVCSICIEDHBNI-UHFFFAOYSA-N 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- ZJFMAASFXLPFHO-UHFFFAOYSA-N n-[4-(9-ethoxy-8-methoxy-2-methyl-3,4,4a,10b-tetrahydro-1h-benzo[c][1,6]naphthyridin-6-yl)phenyl]-4-methylbenzenesulfonamide Chemical compound C1=2C=C(OC)C(OCC)=CC=2C2CN(C)CCC2N=C1C(C=C1)=CC=C1NS(=O)(=O)C1=CC=C(C)C=C1 ZJFMAASFXLPFHO-UHFFFAOYSA-N 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19723161 | 1997-06-03 | ||
EP97108892 | 1997-06-03 | ||
EP98930737A EP0988302B1 (en) | 1997-06-03 | 1998-05-27 | Benzonaphthyridines |
PCT/EP1998/003118 WO1998055481A1 (en) | 1997-06-03 | 1998-05-27 | Benzonaphthyridine |
Publications (1)
Publication Number | Publication Date |
---|---|
SI0988302T1 true SI0988302T1 (en) | 2003-08-31 |
Family
ID=26037086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9830406T SI0988302T1 (en) | 1997-06-03 | 1998-05-27 | Benzonaphthyridines |
Country Status (12)
Country | Link |
---|---|
US (1) | US6384047B1 (xx) |
EP (1) | EP0988302B1 (xx) |
JP (1) | JP2002502403A (xx) |
AT (1) | ATE232864T1 (xx) |
AU (1) | AU8106598A (xx) |
CA (1) | CA2291153A1 (xx) |
DE (1) | DE69811492T2 (xx) |
DK (1) | DK0988302T3 (xx) |
ES (1) | ES2193539T3 (xx) |
PT (1) | PT988302E (xx) |
SI (1) | SI0988302T1 (xx) |
WO (1) | WO1998055481A1 (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR015966A1 (es) * | 1997-10-17 | 2001-05-30 | Smithkline Beecham Corp | Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito |
DE60019894T2 (de) | 1999-01-15 | 2006-01-12 | Altana Pharma Ag | Phenantrhridin-n-oxides mit pde-iv hemmender wirkung |
AU2107700A (en) * | 1999-01-15 | 2000-08-01 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridine-n-oxides with pde-iv inhibiting activity |
NZ512872A (en) | 1999-01-15 | 2003-07-25 | Altana Pharma Ag | Phenylphenanthridines with PDE-IV inhibiting activity |
MXPA02001830A (es) | 1999-08-21 | 2002-08-12 | Byk Gulden Lomberg Chem Fab | Combinacion sinergica de inhibidores de pde y agonista de beta 2 adrenoceptor. |
CZ20031334A3 (cs) | 2000-11-14 | 2003-09-17 | Altana Pharma Ag | Isochinolinové deriváty a jejich použití jako inhibitory |
PT1377574E (pt) | 2001-02-21 | 2005-05-31 | Byk Gulden Lomberg Chem Fab | 6-fenilbenzonaftiridinas |
US7470704B2 (en) | 2002-09-04 | 2008-12-30 | Nycomed Gmbh | Benzonaphthyridines |
ATE360021T1 (de) * | 2002-09-04 | 2007-05-15 | Altana Pharma Ag | Neue benzonaphthyridine |
RS53543B1 (en) | 2004-03-03 | 2015-02-27 | Takeda Gmbh | NEW HYDROXY-6-HETEROARYLPHENANTRIDINES AND THEIR USE AS PDE4 INHIBITORS |
KR101421914B1 (ko) | 2005-03-02 | 2014-07-22 | 다케다 게엠베하 | 6-헤테로시클릴 치환된 헥사히드로페난트리딘 유도체의 신규한 염 |
AU2010258677B2 (en) * | 2009-06-10 | 2016-10-06 | Glaxosmithkline Biologicals S.A. | Benzonaphthyridine-containing vaccines |
AR079451A1 (es) | 2009-12-18 | 2012-01-25 | Nycomed Gmbh | Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina |
WO2013109738A1 (en) | 2012-01-17 | 2013-07-25 | The Trustees Of Columbia University In The City Of New York | Novel phosphodiesterase inhibitors and uses thereof |
WO2015009930A2 (en) | 2013-07-17 | 2015-01-22 | The Trustees Of Columbia University In The City Of New York | Novel phosphodiesterase inhibitors and uses thereof |
CN108299429B (zh) * | 2018-04-09 | 2021-10-08 | 中南大学 | 一类八氢苯并萘啶化合物及其制备方法和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1361441A (en) * | 1970-05-13 | 1974-07-24 | Sandoz Ltd | Benzonaphthyridine derivatives |
DK159431C (da) | 1984-05-10 | 1991-03-18 | Byk Gulden Lomberg Chem Fab | 6-phenyl-3(2h)-pyridazinoner, fremgangsmaade til fremstilling deraf, laegemidler indeholdende disse samt anvendelse af forbindelserne til fremstilling af laegemidler |
EP0247971A3 (en) * | 1986-05-29 | 1990-01-17 | Sandoz Ag | Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin |
MY105344A (en) * | 1990-05-16 | 1994-09-30 | Byk Gulden Lomberg Chemische Fabrik | New sulphonyl compounds |
WO1993009780A1 (de) | 1991-11-15 | 1993-05-27 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Verwendung von sulfonylverbindungen |
DE4310050A1 (de) | 1992-04-11 | 1993-10-14 | Byk Gulden Lomberg Chem Fab | Neue Verwendung von Sulfonylverbindungen |
-
1998
- 1998-05-27 WO PCT/EP1998/003118 patent/WO1998055481A1/en active IP Right Grant
- 1998-05-27 DK DK98930737T patent/DK0988302T3/da active
- 1998-05-27 EP EP98930737A patent/EP0988302B1/en not_active Expired - Lifetime
- 1998-05-27 AU AU81065/98A patent/AU8106598A/en not_active Abandoned
- 1998-05-27 JP JP50142999A patent/JP2002502403A/ja not_active Withdrawn
- 1998-05-27 ES ES98930737T patent/ES2193539T3/es not_active Expired - Lifetime
- 1998-05-27 CA CA002291153A patent/CA2291153A1/en not_active Abandoned
- 1998-05-27 PT PT98930737T patent/PT988302E/pt unknown
- 1998-05-27 US US09/424,841 patent/US6384047B1/en not_active Expired - Fee Related
- 1998-05-27 AT AT98930737T patent/ATE232864T1/de not_active IP Right Cessation
- 1998-05-27 SI SI9830406T patent/SI0988302T1/xx unknown
- 1998-05-27 DE DE69811492T patent/DE69811492T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69811492T2 (de) | 2004-02-05 |
DK0988302T3 (da) | 2003-06-02 |
US6384047B1 (en) | 2002-05-07 |
PT988302E (pt) | 2003-07-31 |
WO1998055481A1 (en) | 1998-12-10 |
EP0988302A1 (en) | 2000-03-29 |
ES2193539T3 (es) | 2003-11-01 |
DE69811492D1 (de) | 2003-03-27 |
AU8106598A (en) | 1998-12-21 |
ATE232864T1 (de) | 2003-03-15 |
JP2002502403A (ja) | 2002-01-22 |
EP0988302B1 (en) | 2003-02-19 |
CA2291153A1 (en) | 1998-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI0988302T1 (en) | Benzonaphthyridines | |
MY106259A (en) | 2-aminopyrimidinone derivatives. | |
WO2000058293A3 (en) | Glucokinase activators | |
AP9701041A0 (en) | Pyridylpyrrole compounds. | |
TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
YU38801A (sh) | Azabicikloalkani kao modulatori ccr5 | |
AU5624699A (en) | Use of 5ht-6 antagonists | |
HK1031869A1 (en) | 1-Ä(1-Substituted-4-piperidinyl)methylÜ-4-piperdine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds. | |
AU1890295A (en) | Piperidines and pyrrolidines | |
CA2262566A1 (en) | Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect | |
HK1009139A1 (en) | New 6-hydroxy and 6-oxo-androstane derivatives active on the cardiovascular system and pharmaceutical compositions containing same | |
IL131407A0 (en) | Tetrahydropyrido compounds medicaments containing the same and the use thereof | |
HRP20010969B1 (en) | Novel piperazinylalkylthiopyrimidine derivatives, | |
IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
PL316870A1 (en) | Derivatives of 5-heterocyclo 1,5-benzodiazepine | |
MX9604762A (es) | Nuevas sulfonamidas y procedimiento para su preparacion. | |
HK1005877A1 (en) | Cyclopentanperhydrophenanth ren-17beta-(3-furyl)-3- derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders | |
MY115795A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | |
WO2000002877A3 (en) | New pharmaceutically active compounds | |
ZA986336B (en) | Medicaments comprising polyhydroxybutylpyrazines novel polyhydroxybutylpyrazines and their preparation | |
AU6290398A (en) | Inclusion complexes in aqueous solution | |
GR3025064T3 (en) | New hydrazino and hydroxyamino-14beta-hydroxyandrostane derivatives active on the cardio-vascular system, processes for their preparation and pharmaceutical compositions containing same | |
MX9704035A (es) | 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos. | |
WO1998023574A8 (en) | Asiatic acid derivatives and medicines for treating wounds, which contains the same | |
GR3031908T3 (en) | Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same |